To provide an optimal solution for urine diagnostics, Greiner Bio-One has developed the new VACUETTE® Urine CCM Tube. The evacuated tube contains a powdered additive, which keeps the urine sample stable for up to 48 hours at room temperature. During this time period, the urine specimen can be stored or transported without refrigeration that would... Read more
The Greiner Group once again improved its sales figures and reached its financial targets in the business year 2016. Besides globalization, diversification and innovation as the key factors of success, the “Plastics for Life” sustainability strategy is at the center of activities. Kremsmünster, May 3, 2017 – The Greiner Group improved its consolidated sales revenues... Read more
Greiner Bio-One North America, Inc. is proud to announce an agreement has been reached to name Greiner Bio-One the new provider of the popular educational event, The Global Summit on Best Practices in Preanalytics, formerly The Phlebotomy Supervisor’s Boot Camp™. Starting in 2017, the Phlebotomy Supervisor’s Boot Camp™ will be known as the Global Summit... Read more
Greiner Bio-One North America, Inc. would like to announce the launch of a new mobile application that will assist in the education and training of users on the safety features of the VACUETTE® Safety Blood Collection Set. The mobile application, named the APPlause Virtual Trainer, walks users step-by-step through the process of activating the safety... Read more
Greiner Bio-One North America, Inc. and Nano3D Biosciences, Inc. are collaborating with University of Colorado and BioServe Space Technologies to broach a new frontier in the biotechnology industry by adapting their products to perform 3D cell culture applications in a microgravity environment. In space, cell cultures spontaneously grow in three dimensions but in microgravity, routine... Read more
Greiner Bio-One GmbH has on 27 February 2017 announced a recommended public offer to the shareholders of Vigmed Holding AB (publ) (“Vigmed”) to tender all shares in Vigmed to GBO. More information availavle at: www.gbo-vigmed.se/en/ (English) www.gbo-vigmed.se/sv/ (Swedish) Read more
Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™... Read more
Greiner Bio-One has been developing plastic products that will help hospitals cut costs without having to sacrifice the quality that their patients need and expect. Employees of the company work as advocates for improving global health through high quality/innovative products and necessary services for those in the healthcare and research fields. This dedication to safety... Read more
Hurricane Matthew devastated parts of the east coast earlier this month, displacing many families and leaving homes under water. Natural disasters like this routinely interrupt access to living quarters, clean water, and reliable sources of food. As a manufacturer in North Carolina, Greiner Bio-One North America, Inc. saw firsthand the devastation caused by Hurricane Matthew... Read more
Greiner Bio-One North America, Inc. (GBO) is a proud sponsor of a National Institutes of Health-funded collaborative effort between Scripps Florida, Cold Springs Harbor Laboratory (CSHL), and Nano3D Biosciences, Inc. (n3D) to advance high-throughput screening (HTS) 3D spheroid based technology aimed at early drug discovery and clinical cancer biology. This work will involve the development... Read more